Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnathan M Lancaster

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Cancer Research|September 11, 2014
Metabolic vulnerabilities in endometrial cancerFrances L Byrne, Ivan K H Poon, Susan C Modesitt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2006
Ovarian cancer. Clinical practice guidelines in oncologyRobert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
JCO Precision Oncology|May 26, 2021
Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic TestingElisha Hughes, Placede Tshiaba, Susanne Wagner, et al.
Gynecologic Oncology|January 6, 2016
Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistanceBernadette M Boac, Yin Xiong, Douglas C Marchion, et al.
Scientific Reports|November 27, 2019
Expression of the BAD pathway is a marker of triple-negative status and poor outcomeBernadette M Boac, Forough Abbasi, Roohi Ismail-Khan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Ovarian cancer. Clinical practice guidelines in oncologyRobert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 31, 2011
Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer riskJennifer Permuth-Wey, Y Ann Chen, Ya-Yu Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2011
BAD phosphorylation determines ovarian cancer chemosensitivity and patient survivalDouglas C Marchion, Hope M Cottrill, Yin Xiong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Inherited determinants of ovarian cancer survivalEllen L Goode, Matthew J Maurer, Thomas A Sellers, et al.
JCO Precision Oncology|July 29, 2021
Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer RiskGregory E Idos, Allison W Kurian, Charité Ricker, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cancer Research|September 11, 2014
Metabolic vulnerabilities in endometrial cancerFrances L Byrne, Ivan K H Poon, Susan C Modesitt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2006
Ovarian cancer. Clinical practice guidelines in oncologyRobert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
JCO Precision Oncology|May 26, 2021
Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic TestingElisha Hughes, Placede Tshiaba, Susanne Wagner, et al.
Gynecologic Oncology|January 6, 2016
Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistanceBernadette M Boac, Yin Xiong, Douglas C Marchion, et al.
Scientific Reports|November 27, 2019
Expression of the BAD pathway is a marker of triple-negative status and poor outcomeBernadette M Boac, Forough Abbasi, Roohi Ismail-Khan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Ovarian cancer. Clinical practice guidelines in oncologyRobert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 31, 2011
Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer riskJennifer Permuth-Wey, Y Ann Chen, Ya-Yu Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2011
BAD phosphorylation determines ovarian cancer chemosensitivity and patient survivalDouglas C Marchion, Hope M Cottrill, Yin Xiong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Inherited determinants of ovarian cancer survivalEllen L Goode, Matthew J Maurer, Thomas A Sellers, et al.
JCO Precision Oncology|July 29, 2021
Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer RiskGregory E Idos, Allison W Kurian, Charité Ricker, et al.
Pageof 8